Copyright Reports & Markets. All rights reserved.

Global VHH Nanobodies Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global VHH Nanobodies Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Monovalent Nanobodies
    • 1.3.3 Bivalent Nanobodies
    • 1.3.4 Bispecific Nanobodies
    • 1.3.5 Multivalent Nanobodies
    • 1.3.6 Fused Nanobodies
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global VHH Nanobodies Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Treatment
    • 1.4.3 Diagnosis
    • 1.4.4 Research
  • 1.5 Global VHH Nanobodies Market Size & Forecast
    • 1.5.1 Global VHH Nanobodies Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global VHH Nanobodies Sales Quantity (2020-2031)
    • 1.5.3 Global VHH Nanobodies Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Sino Biological
    • 2.1.1 Sino Biological Details
    • 2.1.2 Sino Biological Major Business
    • 2.1.3 Sino Biological VHH Nanobodies Product and Services
    • 2.1.4 Sino Biological VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Sino Biological Recent Developments/Updates
  • 2.2 GenScript
    • 2.2.1 GenScript Details
    • 2.2.2 GenScript Major Business
    • 2.2.3 GenScript VHH Nanobodies Product and Services
    • 2.2.4 GenScript VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 GenScript Recent Developments/Updates
  • 2.3 Proteintech Group
    • 2.3.1 Proteintech Group Details
    • 2.3.2 Proteintech Group Major Business
    • 2.3.3 Proteintech Group VHH Nanobodies Product and Services
    • 2.3.4 Proteintech Group VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Proteintech Group Recent Developments/Updates
  • 2.4 Abiocenter
    • 2.4.1 Abiocenter Details
    • 2.4.2 Abiocenter Major Business
    • 2.4.3 Abiocenter VHH Nanobodies Product and Services
    • 2.4.4 Abiocenter VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Abiocenter Recent Developments/Updates
  • 2.5 MerryBio
    • 2.5.1 MerryBio Details
    • 2.5.2 MerryBio Major Business
    • 2.5.3 MerryBio VHH Nanobodies Product and Services
    • 2.5.4 MerryBio VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 MerryBio Recent Developments/Updates
  • 2.6 Pregene
    • 2.6.1 Pregene Details
    • 2.6.2 Pregene Major Business
    • 2.6.3 Pregene VHH Nanobodies Product and Services
    • 2.6.4 Pregene VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Pregene Recent Developments/Updates
  • 2.7 Cusabio
    • 2.7.1 Cusabio Details
    • 2.7.2 Cusabio Major Business
    • 2.7.3 Cusabio VHH Nanobodies Product and Services
    • 2.7.4 Cusabio VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Cusabio Recent Developments/Updates
  • 2.8 Biocytogen
    • 2.8.1 Biocytogen Details
    • 2.8.2 Biocytogen Major Business
    • 2.8.3 Biocytogen VHH Nanobodies Product and Services
    • 2.8.4 Biocytogen VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Biocytogen Recent Developments/Updates
  • 2.9 Thermo Fisher Scientific
    • 2.9.1 Thermo Fisher Scientific Details
    • 2.9.2 Thermo Fisher Scientific Major Business
    • 2.9.3 Thermo Fisher Scientific VHH Nanobodies Product and Services
    • 2.9.4 Thermo Fisher Scientific VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.10 QVQuality
    • 2.10.1 QVQuality Details
    • 2.10.2 QVQuality Major Business
    • 2.10.3 QVQuality VHH Nanobodies Product and Services
    • 2.10.4 QVQuality VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 QVQuality Recent Developments/Updates
  • 2.11 HUABIO
    • 2.11.1 HUABIO Details
    • 2.11.2 HUABIO Major Business
    • 2.11.3 HUABIO VHH Nanobodies Product and Services
    • 2.11.4 HUABIO VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 HUABIO Recent Developments/Updates
  • 2.12 Jackson ImmunoResearch
    • 2.12.1 Jackson ImmunoResearch Details
    • 2.12.2 Jackson ImmunoResearch Major Business
    • 2.12.3 Jackson ImmunoResearch VHH Nanobodies Product and Services
    • 2.12.4 Jackson ImmunoResearch VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Jackson ImmunoResearch Recent Developments/Updates

3 Competitive Environment: VHH Nanobodies by Manufacturer

  • 3.1 Global VHH Nanobodies Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global VHH Nanobodies Revenue by Manufacturer (2020-2025)
  • 3.3 Global VHH Nanobodies Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of VHH Nanobodies by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 VHH Nanobodies Manufacturer Market Share in 2024
    • 3.4.3 Top 6 VHH Nanobodies Manufacturer Market Share in 2024
  • 3.5 VHH Nanobodies Market: Overall Company Footprint Analysis
    • 3.5.1 VHH Nanobodies Market: Region Footprint
    • 3.5.2 VHH Nanobodies Market: Company Product Type Footprint
    • 3.5.3 VHH Nanobodies Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global VHH Nanobodies Market Size by Region
    • 4.1.1 Global VHH Nanobodies Sales Quantity by Region (2020-2031)
    • 4.1.2 Global VHH Nanobodies Consumption Value by Region (2020-2031)
    • 4.1.3 Global VHH Nanobodies Average Price by Region (2020-2031)
  • 4.2 North America VHH Nanobodies Consumption Value (2020-2031)
  • 4.3 Europe VHH Nanobodies Consumption Value (2020-2031)
  • 4.4 Asia-Pacific VHH Nanobodies Consumption Value (2020-2031)
  • 4.5 South America VHH Nanobodies Consumption Value (2020-2031)
  • 4.6 Middle East & Africa VHH Nanobodies Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global VHH Nanobodies Sales Quantity by Type (2020-2031)
  • 5.2 Global VHH Nanobodies Consumption Value by Type (2020-2031)
  • 5.3 Global VHH Nanobodies Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global VHH Nanobodies Sales Quantity by Application (2020-2031)
  • 6.2 Global VHH Nanobodies Consumption Value by Application (2020-2031)
  • 6.3 Global VHH Nanobodies Average Price by Application (2020-2031)

7 North America

  • 7.1 North America VHH Nanobodies Sales Quantity by Type (2020-2031)
  • 7.2 North America VHH Nanobodies Sales Quantity by Application (2020-2031)
  • 7.3 North America VHH Nanobodies Market Size by Country
    • 7.3.1 North America VHH Nanobodies Sales Quantity by Country (2020-2031)
    • 7.3.2 North America VHH Nanobodies Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe VHH Nanobodies Sales Quantity by Type (2020-2031)
  • 8.2 Europe VHH Nanobodies Sales Quantity by Application (2020-2031)
  • 8.3 Europe VHH Nanobodies Market Size by Country
    • 8.3.1 Europe VHH Nanobodies Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe VHH Nanobodies Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific VHH Nanobodies Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific VHH Nanobodies Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific VHH Nanobodies Market Size by Region
    • 9.3.1 Asia-Pacific VHH Nanobodies Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific VHH Nanobodies Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America VHH Nanobodies Sales Quantity by Type (2020-2031)
  • 10.2 South America VHH Nanobodies Sales Quantity by Application (2020-2031)
  • 10.3 South America VHH Nanobodies Market Size by Country
    • 10.3.1 South America VHH Nanobodies Sales Quantity by Country (2020-2031)
    • 10.3.2 South America VHH Nanobodies Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa VHH Nanobodies Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa VHH Nanobodies Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa VHH Nanobodies Market Size by Country
    • 11.3.1 Middle East & Africa VHH Nanobodies Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa VHH Nanobodies Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 VHH Nanobodies Market Drivers
  • 12.2 VHH Nanobodies Market Restraints
  • 12.3 VHH Nanobodies Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of VHH Nanobodies and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of VHH Nanobodies
  • 13.3 VHH Nanobodies Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 VHH Nanobodies Typical Distributors
  • 14.3 VHH Nanobodies Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global VHH Nanobodies market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    In the peripheral blood of camel species such as alpacas, there is an antibody that naturally lacks light chains. It is a natural dimer formed by two heavy chains, called a heavy chain antibody. The variable region of this heavy chain antibody is called VHH, which can bind to antigens as a single molecule and has high affinity and high specificity. VHH crystals are 2.5nm, 4nm long, and have a molecular weight of only 15 kDa, so they are also called nano antibodies. VHH is not as easy to adhere to each other as artificially modified single-chain antibody fragments (scFV), but is more stable and can even be stored at room temperature. The half-life of nano antibodies can be extended and antibody drugs can be produced by constructing bifunctional domain or trifunctional domain antibodies that recognize HSA, or constructing Fc fusion proteins.
    This report is a detailed and comprehensive analysis for global VHH Nanobodies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global VHH Nanobodies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
    Global VHH Nanobodies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
    Global VHH Nanobodies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
    Global VHH Nanobodies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for VHH Nanobodies
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global VHH Nanobodies market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, Pregene, Cusabio, Biocytogen, Thermo Fisher Scientific, QVQuality, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    VHH Nanobodies market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Monovalent Nanobodies
    Bivalent Nanobodies
    Bispecific Nanobodies
    Multivalent Nanobodies
    Fused Nanobodies
    Market segment by Application
    Treatment
    Diagnosis
    Research
    Major players covered
    Sino Biological
    GenScript
    Proteintech Group
    Abiocenter
    MerryBio
    Pregene
    Cusabio
    Biocytogen
    Thermo Fisher Scientific
    QVQuality
    HUABIO
    Jackson ImmunoResearch
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe VHH Nanobodies product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of VHH Nanobodies, with price, sales quantity, revenue, and global market share of VHH Nanobodies from 2020 to 2025.
    Chapter 3, the VHH Nanobodies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the VHH Nanobodies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and VHH Nanobodies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of VHH Nanobodies.
    Chapter 14 and 15, to describe VHH Nanobodies sales channel, distributors, customers, research findings and conclusion.

    Buy now